News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News AHA 2020 AFFIRM-AHF: IV Iron Supplementation Linked to Fewer Repeat Hospitalizations for HF L.A. McKeown November 13, 2020
News Conference News ACC 2020 VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events L.A. McKeown March 28, 2020
News Conference News VIVA 2019 Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’ L.A. McKeown November 07, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Conference News ISET 2019 PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research Caitlin E. Cox January 28, 2019
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News TCT 2018 RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation Todd Neale September 26, 2018
News Conference News TCT 2018 Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation Todd Neale September 25, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Conference News VIVA 2017 EVAR Outcomes Equivalent Between Men and Women, Registries Show L.A. McKeown September 14, 2017
News Conference News TCT 2016 Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field? Todd Neale October 30, 2016